Literature DB >> 14742442

Analysis of SOCS-3 promoter responses to interferon gamma.

Luana Gatto1, Chiara Berlato, Valeria Poli, Silvia Tininini, Ichiko Kinjyo, Akihiko Yoshimura, Marco A Cassatella, Flavia Bazzoni.   

Abstract

SOCS-3 (suppressor of cytokine signaling 3) is an intracellular protein that is selectively and rapidly induced by appropriate agonists and that modulates responses of immune cells to cytokines by interfering with the Janus kinase/signal transducer and activator of transcription (Jak/STAT) pathway. On the basis of the observations that interferon gamma (IFNgamma) up-regulates SOCS-3 gene and protein expression in primary mouse macrophages, J774 macrophage cell line and embryonal fibroblasts, we investigated which sequences of the 5' SOCS-3 gene are responsive to IFNgamma. By promoter deletion analysis we identified a functional IFNgamma-responsive element, located at nucleotides -72/-64 upstream from the transcription initiation, whose presence and integrity is necessary to ensure responsiveness to IFNgamma. This element contains a STAT consensus binding sequence (SOCS-3/STAT-binding element (SBE)) whose specific mutation totally abolished the responsiveness to IFNgamma. In contrast, discrete deletion of other 5' regions of the SOCS-3 promoter did not substantially modify the inducibility by IFNgamma. Electromobility shift assay analyses revealed that IFNgamma promotes specific DNA binding activities to an oligonucleotide probe containing the SOCS-3/SBE sequence. Even though IFNgamma triggered tyrosine phosphorylation of both STAT1 and STAT3 in macrophages and J774 cells, only STAT1 was appropriately activated and thus found to specifically bind to the SOCS-3/SBE oligonucleotide probe. Accordingly, IFNgamma-induced SOCS-3 protein expression was not impaired in STAT3-deficient embryonal fibroblasts. Taken together, these results demonstrate that the induction of SOCS-3 by IFNgamma depends upon the presence of a STAT-binding element in the SOCS-3 promoter that is specifically activated by STAT1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742442     DOI: 10.1074/jbc.M308999200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  The Aryl Hydrocarbon Receptor Modulates Production of Cytokines and Reactive Oxygen Species and Development of Myocarditis during Trypanosoma cruzi Infection.

Authors:  Andréia Barroso; Melisa Gualdrón-López; Lísia Esper; Fátima Brant; Ronan R S Araújo; Matheus B H Carneiro; Thiago V Ávila; Danielle G Souza; Leda Q Vieira; Milene A Rachid; Herbert B Tanowitz; Mauro M Teixeira; Fabiana S Machado
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

2.  Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models.

Authors:  Y D Kim; Y H Kim; Y M Cho; D K Kim; S W Ahn; J M Lee; D Chanda; M Shong; C H Lee; H S Choi
Journal:  Diabetologia       Date:  2012-02-21       Impact factor: 10.122

3.  Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders.

Authors:  Arunava Ghosh; Kalipada Pahan
Journal:  J Biol Chem       Date:  2012-06-08       Impact factor: 5.157

4.  IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain.

Authors:  Ling Zhang; Donna B Badgwell; Jack J Bevers; Karni Schlessinger; Peter J Murray; David E Levy; Stephanie S Watowich
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

5.  Nuclear localization of pyruvate dehydrogenase complex-E2 (PDC-E2), a mitochondrial enzyme, and its role in signal transducer and activator of transcription 5 (STAT5)-dependent gene transcription.

Authors:  Fu-Yu Chueh; King-Fu Leong; Robert J Cronk; Srividya Venkitachalam; Samantha Pabich; Chao-Lan Yu
Journal:  Cell Signal       Date:  2011-03-17       Impact factor: 4.315

6.  STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.

Authors:  Yi Li; Jasper Deuring; Maikel P Peppelenbosch; Ernst J Kuipers; Colin de Haar; C Janneke van der Woude
Journal:  Mol Med       Date:  2012-12-20       Impact factor: 6.354

7.  Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study.

Authors:  Matthew E Talbert; Carl D Langefeld; Julie Ziegler; Josyf C Mychaleckyj; Steven M Haffner; Jill M Norris; Donald W Bowden
Journal:  Hum Genet       Date:  2008-12-13       Impact factor: 4.132

8.  Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes.

Authors:  Brandi J Baker; Hongwei Qin; Etty N Benveniste
Journal:  Glia       Date:  2008-08-15       Impact factor: 7.452

9.  Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.

Authors:  Oxana Norkina; Angela Dolganiuc; Donna Catalano; Karen Kodys; Pranoti Mandrekar; Amber Syed; Marian Efros; Gyongyi Szabo
Journal:  Alcohol Clin Exp Res       Date:  2008-07-09       Impact factor: 3.455

10.  Regulation of multiple cytokine signalling pathways by SOCS3 is independent of SOCS2.

Authors:  Hiu Kiu; Christopher J Greenhalgh; Anne Thaus; Douglas J Hilton; Nicos A Nicola; Warren S Alexander; Andrew W Roberts
Journal:  Growth Factors       Date:  2009-12       Impact factor: 2.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.